Showing results (31-40 of 77) with videos related to
Sort By:
Pageof 8
Journal of Cardiology|February 10, 2025
Structural instability of ryanodine receptor 2 causes endoplasmic reticulum (ER) dysfunction as well as sarcoplasmic reticulum (SR) dysfunctionHitoshi Uchinoumi, Yoshihide Nakamura, Takeshi Suetomi, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 6, 2002
Myocardial ischemia in Kawasaki disease: evaluation with dipyridamole stress technetium 99m tetrofosmin scintigraphyTsuyoshi Fukuda, Masatoshi Ishibashi, Tatsuo Yokoyama, et al.Heart Rhythm|August 16, 2019
Catheter ablation in children and patients with congenital heart disease: Review of 1021 procedures at a high-volume single center in JapanYuko Kato, Tsugutoshi Suzuki, Yoko Yoshida, et al.The Annals of Thoracic Surgery|June 3, 2014
Novel technique for implantation of a cardioverter defibrillator in childrenTomomitsu Kanaya, Kyoichi Nishigaki, Kazuhiko Ishimaru, et al.Biochemical and Biophysical Research Communications|February 22, 2023
Herpud1 modulates hypertrophic signals independently of calmodulin nuclear translocation in rat myocardium-derived H9C2 cellsRiko Fujioka, Takeshi Yamamoto, Akihiro Maruta, et al.Scientific Reports|April 1, 2021
Enhancing calmodulin binding to ryanodine receptor is crucial to limit neuronal cell loss in Alzheimer diseaseYoshihide Nakamura, Takeshi Yamamoto, Xiaojuan Xu, et al.Annals of Nuclear Medicine|October 14, 2019
Manual on the proper use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trialsMakoto Hosono, Hideharu Ikebuchi, Seigo Kinuya, et al.Biochemistry and Biophysics Reports|March 22, 2022
Herpud1 suppress angiotensin II induced hypertrophy in cardiomyocytesMei Mikawa, Chihiro Sakai, Takeshi Yamamoto, et al.Pediatric Cardiology|November 10, 2017
Safety and Efficacy of Radiofrequency Catheter Ablation for Tachyarrhythmia in Children Weighing Less Than 10 kgNoriyasu Ozaki, Yoshihide Nakamura, Tsugutoshi Suzuki, et al.Chemical & Pharmaceutical Bulletin|April 20, 2002
Synthesis and antitumor activity of novel pyrimidinyl pyrazole derivatives. II. Optimization of the phenylpiperazine moiety of 1-[5-methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-3-phenylpiperazinyl-1-trans-propenesHiroyuki Naito, Satoru Ohsuki, Masamichi Sugimori, et al.Pageof 8